Your shopping cart is currently empty

GP2-114 is a catecholamine motility mimetic that produces current-dependent cardiovascular effects when administered via transdermal iontophoresis and can be used to study coronary artery disease (CAD).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $658 | In Stock | In Stock | |
| 5 mg | $1,280 | In Stock | In Stock | |
| 10 mg | $2,220 | In Stock | In Stock | |
| 25 mg | $4,290 | In Stock | In Stock | |
| 50 mg | $5,790 | - | In Stock | |
| 100 mg | $7,850 | - | In Stock |
| Description | GP2-114 is a catecholamine motility mimetic that produces current-dependent cardiovascular effects when administered via transdermal iontophoresis and can be used to study coronary artery disease (CAD). |
| In vitro | A 50% mixture of the RR and RS enantiomer forms of GP-2-128 (GP-2-114) has the same pharmacological characteristics as the pure RR enantiomer; GP-2-114 produces current-dependent cardiovascular effects when administered by transdermal iontophoresis. |
| Molecular Weight | 344.4 |
| Formula | C19H24N2O4 |
| Cas No. | 130783-39-0 |
| Smiles | C(CNC(CCC1=CC=C(C(N)=O)C=C1)C)(O)C2=CC(O)=C(O)C=C2 |
| Relative Density. | 1.266g/cm3 |
| Storage | store at low temperature,The compound is unstable in solution. Please use soon | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.